General Information of the Protein
Protein ID
PT06468
Protein Name
Period circadian protein homolog 2
Secondarily
Protein Name
Circadian clock protein PERIOD 2
Gene Name
PER2
Secondarily
Gene Name
KIAA0347
Sequence
MNGYAEFPPSPSNPTKEPVEPQPSQVPLQEDVDMSSGSSGHETNENCSTGRDSQGSDCDDSGKELGMLVEPPDARQSPDTFSLMMAKSEHNPSTSGCSSDQSSKVDTHKELIKTLKELKVHLPADKKAKGKASTLATLKYALRSVKQVKANEEYYQLLMSSEGHPCGADVPSYTVEEMESVTSEHIVKNADMFAVAVSLVSGKILYISDQVASIFHCKRDAFSDAKFVEFLAPHDVGVFHSFTSPYKLPLWSMCSGADSFTQECMEEKSFFCRVSVRKSHENEIRYHPFRMTPYLVKVRDQQGAESQLCCLLLAERVHSGYEAPRIPPEKRIFTTTHTPNCLFQDVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQSGGQPFDYSPIRFRARNGEYITLDTSWSSFINPWSRKISFIIGRHKVRVGPLNEDVFAAHPCTEEKALHPSIQELTEQIHRLLLQPVPHSGSSGYGSLGSNGSHEHLMSQTSSSDSNGHEDSRRRRAEICKNGNKTKNRSHYSHESGEQKKKSVTEMQTNPPAEKKAVPAMEKDSLGVSFPEELACKNQPTCSYQQISCLDSVIRYLESCNEAATLKRKCEFPANVPALRSSDKRKATVSPGPHAGEAEPPSRVNSRTGVGTHLTSLALPGKAESVASLTSQCSYSSTIVHVGDKKPQPELEMVEDAASGPESLDCLAGPALACGLSQEKEPFKKLGLTKEVLAAHTQKEEQSFLQKFKEIRKLSIFQSHCHYYLQERSKGQPSERTAPGLRNTSGIDSPWKKTGKNRKLKSKRVKPRDSSESTGSGGPVSARPPLVGLNATAWSPSDTSQSSCPAVPFPAPVPAAYSLPVFPAPGTVAAPPAPPHASFTVPAVPVDLQHQFAVQPPPFPAPLAPVMAFMLPSYSFPSGTPNLPQAFFPSQPQFPSHPTLTSEMASASQPEFPSRTSIPRQPCACPATRATPPSAMGRASPPLFQSRSSSPLQLNLLQLEEAPEGGTGAMGTTGATETAAVGADCKPGTSRDQQPKAPLTRDEPSDTQNSDALSTSSGLLNLLLNEDLCSASGSAASESLGSGSLGCDASPSGAGSSDTSHTSKYFGSIDSSENNHKAKMNTGMEESEHFIKCVLQDPIWLLMADADSSVMMTYQLPSRNLEAVLKEDREKLKLLQKLQPRFTESQKQELREVHQWMQTGGLPAAIDVAECVYCENKEKGNICIPYEEDIPSLGLSEVSDTKEDENGSPLNHRIEEQT
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Unclassified protein
Function
Transcriptional repressor which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndrome and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress BMAL1 transcription, respectively. PER1 and PER2 proteins transport CRY1 and CRY2 into the nucleus with appropriate circadian timing, but also contribute directly to repression of clock-controlled target genes through interaction with several classes of RNA-binding proteins, helicases and others transcriptional repressors. PER appears to regulate circadian control of transcription by at least three different modes. First, interacts directly with the CLOCK-BMAL1 at the tail end of the nascent transcript peak to recruit complexes containing the SIN3-HDAC that remodel chromatin to repress transcription. Second, brings H3K9 methyltransferases such as SUV39H1 and SUV39H2 to the E-box elements of the circadian target genes, like PER2 itself or PER1. The recruitment of each repressive modifier to the DNA seems to be very precisely temporally orchestrated by the large PER complex, the deacetylases acting before than the methyltransferases. Additionally, large PER complexes are also recruited to the target genes 3' termination site through interactions with RNA-binding proteins and helicases that may play a role in transcription termination to regulate transcription independently of CLOCK-BMAL1 interactions. Recruitment of large PER complexes to the elongating polymerase at PER and CRY termination sites inhibited SETX action, impeding RNA polymerase II release and thereby repressing transcriptional reinitiation. May propagate clock information to metabolic pathways via the interaction with nuclear receptors. Coactivator of PPARA and corepressor of NR1D1, binds rhythmically at the promoter of nuclear receptors target genes like BMAL1 or G6PC1. Directly and specifically represses PPARG proadipogenic activity by blocking PPARG recruitment to target promoters and thereby inhibiting transcriptional activation. Required for fatty acid and lipid metabolism, is involved as well in the regulation of circulating insulin levels. Plays an important role in the maintenance of cardiovascular functions through the regulation of NO and vasodilatatory prostaglandins production in aortas. Controls circadian glutamate uptake in synaptic vesicles through the regulation of VGLUT1 expression. May also be involved in the regulation of inflammatory processes. Represses the CLOCK-BMAL1 induced transcription of BHLHE40/DEC1 and ATF4. Negatively regulates the formation of the TIMELESS-CRY1 complex by competing with TIMELESS for binding to CRY1.
    Show/Hide
Uniprot ID
Primary ID:
O15055

Secondarily ID:
A2I2P7
Q4ZG49
Q6DT41
Q9UQ45
    Show/Hide
Ensembl ID
ENSG00000132326
HGNC ID
HGNC:8846
Subcellular Location
Nucleus
Cytoplasm
Cytoplasm
Perinuclear region
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000043 , U2OS
Compound ID Compound Name Compound Formula
CP0443632
1-carbazol-9-yl-3-(1,1-dioxo-1,2,5-thiadiazolidin-2-yl)propan-2-ol
   Show/Hide
C17H19N3O3S
 1
1
EC50 = 42 nM
   TI
   LI
   LO
   TS
CP0417254
1-carbazol-9-yl-3-(3,3-dioxo-1,3,4-oxathiazinan-4-yl)propan-2-ol
   Show/Hide
C18H20N2O4S
 1
1
EC50 = 73 nM
   TI
   LI
   LO
   TS
CP0417258
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-cyclobutylmethanesulfonamide
   Show/Hide
C20H24N2O3S
 1
1
EC50 = 129 nM
   TI
   LI
   LO
   TS
CP0413851
1-carbazol-9-yl-3-(5-methyl-1,1-dioxo-1,2,5-thiadiazolidin-2-yl)propan-2-ol
   Show/Hide
C18H21N3O3S
 1
1
EC50 = 132 nM
   TI
   LI
   LO
   TS
CP0126904
1-carbazol-9-yl-3-(1,1-dioxo-1,2-thiazolidin-2-yl)propan-2-ol
   Show/Hide
C18H20N2O3S
 1
1
EC50 = 144 nM
   TI
   LI
   LO
   TS
CP0456802
1-carbazol-9-yl-3-(1,1-dioxothiazinan-2-yl)propan-2-ol
   Show/Hide
C19H22N2O3S
 1
1
EC50 = 173 nM
   TI
   LI
   LO
   TS
CP0413848
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(2-methylpropyl)methanesulfonamide
   Show/Hide
C20H26N2O3S
 1
1
EC50 = 178 nM
   TI
   LI
   LO
   TS
CP0562287
1-carbazol-9-yl-3-(1,1-dioxothiazetidin-2-yl)propan-2-ol
   Show/Hide
C17H18N2O3S
 1
1
EC50 = 190 nM
   TI
   LI
   LO
   TS
CP0558193
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)ethanesulfonamide
   Show/Hide
C22H24N2O4S
 1
1
EC50 = 197 nM
   TI
   LI
   LO
   TS
CP0456803
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-phenylmethanesulfonamide
   Show/Hide
C22H22N2O3S
 1
1
EC50 = 272 nM
   TI
   LI
   LO
   TS
CP0413849
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)-2-methoxyethanesulfonamide
   Show/Hide
C23H26N2O5S
 1
1
EC50 = 288 nM
   TI
   LI
   LO
   TS
CP0413847
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-cyclopentylmethanesulfonamide
   Show/Hide
C21H26N2O3S
 1
1
EC50 = 308 nM
   TI
   LI
   LO
   TS
CP0390392
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)-2-methylpropane-1-sulfonamide
   Show/Hide
C24H28N2O4S
 1
1
EC50 = 361 nM
   TI
   LI
   LO
   TS
CP0413850
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)butane-1-sulfonamide
   Show/Hide
C24H28N2O4S
 1
1
EC50 = 374 nM
   TI
   LI
   LO
   TS
CP0417253
1-carbazol-9-yl-3-(1,1-dioxo-1,2,6-thiadiazinan-2-yl)propan-2-ol
   Show/Hide
C18H21N3O3S
 1
1
EC50 = 384 nM
   TI
   LI
   LO
   TS
CP0390393
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(3-fluorophenyl)methanesulfonamide
   Show/Hide
C22H21FN2O3S
 1
1
EC50 = 400 nM
   TI
   LI
   LO
   TS
CP0443604
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-propylmethanesulfonamide
   Show/Hide
C19H24N2O3S
 1
1
EC50 = 408 nM
   TI
   LI
   LO
   TS
CP0417259
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)-1-phenylmethanesulfonamide
   Show/Hide
C27H26N2O4S
 1
1
EC50 = 415 nM
   TI
   LI
   LO
   TS
CP0417252
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)propane-2-sulfonamide
   Show/Hide
C23H26N2O4S
 1
1
EC50 = 438 nM
   TI
   LI
   LO
   TS
CP0443600
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-cyclopropylmethanesulfonamide
   Show/Hide
C19H22N2O3S
 1
1
EC50 = 446 nM
   TI
   LI
   LO
   TS
CP0417260
N-(3-carbazol-9-yl-2-hydroxypropyl)methanesulfonamide
   Show/Hide
C16H18N2O3S
 1
1
EC50 = 479 nM
   TI
   LI
   LO
   TS
CP0456805
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-ethylmethanesulfonamide
   Show/Hide
C18H22N2O3S
 1
1
EC50 = 505 nM
   TI
   LI
   LO
   TS
CP0512393
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-propan-2-ylmethanesulfonamide
   Show/Hide
C19H24N2O3S
 1
1
EC50 = 511 nM
   TI
   LI
   LO
   TS
CP0413845
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)propane-1-sulfonamide
   Show/Hide
C23H26N2O4S
 1
1
EC50 = 516 nM
   TI
   LI
   LO
   TS
CP0417262
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-cyclohexylmethanesulfonamide
   Show/Hide
C22H28N2O3S
 1
1
EC50 = 532 nM
   TI
   LI
   LO
   TS
CP0512392
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)cyclopropanesulfonamide
   Show/Hide
C23H24N2O4S
 1
1
EC50 = 557 nM
   TI
   LI
   LO
   TS
CP0516462
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(4,4-difluorocyclohexyl)methanesulfonamide
   Show/Hide
C22H26F2N2O3S
 1
1
EC50 = 690 nM
   TI
   LI
   LO
   TS
CP0448179
1-carbazol-9-yl-3-(6-methyl-1,1-dioxo-1,2,6-thiadiazinan-2-yl)propan-2-ol
   Show/Hide
C19H23N3O3S
 1
1
EC50 = 726 nM
   TI
   LI
   LO
   TS
CP0443602
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-methylmethanesulfonamide
   Show/Hide
C17H20N2O3S
 1
1
EC50 = 781 nM
   TI
   LI
   LO
   TS
CP0417255
N-benzyl-N-(3-carbazol-9-yl-2-hydroxypropyl)methanesulfonamide
   Show/Hide
C23H24N2O3S
 1
1
EC50 = 818 nM
   TI
   LI
   LO
   TS
CP0390419
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(oxan-4-yl)methanesulfonamide
   Show/Hide
C21H26N2O4S
 1
1
EC50 = 819 nM
   TI
   LI
   LO
   TS
CP0014050
MLS000110334
   Show/Hide
C21H22N2O4S
 1
1
EC50 = 870 nM
   TI
   LI
   LO
   TS
CP0474857
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(4-fluorophenyl)methanesulfonamide
   Show/Hide
C22H21FN2O3S
 1
1
EC50 = 939 nM
   TI
   LI
   LO
   TS
CP0443599
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)cyclohexanesulfonamide
   Show/Hide
C26H30N2O4S
 1
1
EC50 = 1002 nM
   TI
   LI
   LO
   TS
CP0516463
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(2-methoxyethyl)methanesulfonamide
   Show/Hide
C19H24N2O4S
 1
1
EC50 = 1024 nM
   TI
   LI
   LO
   TS
CP0390417
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)benzenesulfonamide
   Show/Hide
C26H24N2O4S
 1
1
EC50 = 1087 nM
   TI
   LI
   LO
   TS
CP0413844
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)oxolane-3-sulfonamide
   Show/Hide
C24H26N2O5S
 1
1
EC50 = 1177 nM
   TI
   LI
   LO
   TS
CP0456804
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(3,3-difluorocyclobutyl)methanesulfonamide
   Show/Hide
C20H22F2N2O3S
 1
1
EC50 = 1272 nM
   TI
   LI
   LO
   TS
CP0417256
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(2-fluorophenyl)methanesulfonamide
   Show/Hide
C22H21FN2O3S
 1
1
EC50 = 2549 nM
   TI
   LI
   LO
   TS
CP0413846
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(oxetan-3-yl)methanesulfonamide
   Show/Hide
C19H22N2O4S
 1
1
EC50 = 3533 nM
   TI
   LI
   LO
   TS
CP0417257
N-(3-carbazol-9-yl-2-hydroxypropyl)-N-pyridin-2-ylmethanesulfonamide
   Show/Hide
C21H21N3O3S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS